Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells

Erythropoietin receptor (EpoR) has been reported to be overexpressed in tumours and has raised safety concerns regarding the use of erythropoiesis-stimulating agents (ESAs) to treat anaemia in cancer patients. To investigate the potential for EpoR to be overexpressed in tumours, we have evaluated hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinclair, A M, Rogers, N, Busse, L, Archibeque, I, Brown, W, Kassner, P D, Watson, J E V, Arnold, G E, Nguyen, K C Q, Powers, S, Elliott, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275479/
https://www.ncbi.nlm.nih.gov/pubmed/18349818
http://dx.doi.org/10.1038/sj.bjc.6604220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275479/
https://www.ncbi.nlm.nih.gov/pubmed/18349818
http://dx.doi.org/10.1038/sj.bjc.6604220

Ejemplares similares